GlobeNewswire·Mar 10, 2026, 8:00 AM ET

VTAK Announces Definitive Merger Agreement to Acquire 100% of Fly Flyte Inc.

CRTDD VTAK

Catheter Precision, Inc. (NYSE: VTAK) completed the acquisition of the remaining 80.02% equity interest in Flyte, Inc. from Creatd, Inc., resulting in 100% ownership of the AI-enabled regional aviation operator.
The transaction converts Flyte from a minority strategic investment into a wholly owned operating subsidiary, allowing all operations, assets, & economics to be consolidated within VTAK financial statements.
Flyte operates under FAA 14 CFR Part 135 certification using Cirrus Vision Jets on high-frequency, short-haul regional routes where commercial airline capacity is constrained.
Current revenue generation relies on aircraft equipped with advanced safety systems, including whole-aircraft parachute technology & Safe Return™ autonomous landing capability.
Full ownership provides VTAK with direct exposure to operating performance, immediate cash flow, & tangible asset backing through certified infrastructure & a scalable fleet.
CEO David Jenkins stated the acquisition marks a defining inflection point that enhances VTAK's valuation profile through consolidated revenues & potential for substantial operating leverage.
Flyte operates via its subsidiary Ponderosa Air, LLC, emphasizing capital efficiency, high aircraft utilization, & disciplined expansion aligned with demand.
The structure allows VTAK to generate real operating data & revenue today while maintaining optionality to participate in future regional air mobility & electric aircraft evolution.
Flyte CEO Marc Sellouk highlighted that listing on a national exchange & becoming a wholly owned subsidiary provides aligned governance, capital support, & a clear execution framework.
This press release references a Form 8-K filed March 9, 2026, for additional transaction details subject to customary closing conditions including shareholder approval.